Dr. Di Meglio discussed his research on trajectories of multidimensional worry in patients with early-stage breast cancer.
Advertisement
Latest News
The investigators conducted semistructured phone interviews to recruit patients with bladder, prostate, or kidney cancer.
Garg explained the importance of investigating disparities across racial and ethnic groups in the Hispanic community.
Uterine carcinosarcoma is responsible for more than 16% of all deaths caused by uterine malignancy, despite its rarity.
Uterine cancer, including endometrial carcinoma, is a major public health concern in the EU.
The findings were presented as an abstract during the American Society of Clinical Oncology 2025 Annual Meeting.
Dr. Loibl discusses the importance of involving nurses in breast cancer treatment to mitigate medication side effects.
Chronic GVHD can increase the risk of infections, graft failure, and multi-organ dysfunction in patients.
Researchers compared outcomes between patients who received prior CAR-T therapy and those who received chemotherapy.
The open-label phase 2 clinical trial enrolled 33 patients with resectable, high-risk ccRCC.
Optimal management of non-clear cell renal cell carcinoma remains an unmet need.
While RCC is the leading cause of cancer-related mortality, early detection can greatly improve disease outcomes.
New research shows why it's critical to consider integrating a survivorship oncology nurse navigator within cancer clinics.
Advertisement
Advertisement
Our Contributors
Theresa Brown, RNTheresa Brown, RN, is the New York Times best-selling author of "Healing" and "The Shift."
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC.
Milagros Elia, MA, APRN, ANP-BCMilagros R. Elia, MA, APRN, ANP-BC, has 25+ years of oncology experience and is a highly regarded activist.
Pamela K. Ginex, EdD, MPH, RN, OCNPamela K. Ginex, EdD, MPH, RN, OCN, is an Assistant Professor at the Stony Brook University School of Nursing.
Teresa Hagan Thomas, PhD, RNTeresa Hagan Thomas, PhD, RN, is an Assistant Professor at the University of Pittsburgh School of Nursing.
Amanda Brink, DNP, APRN, FNP-BC, AOCNPAmanda Brink, DNP, APRN, FNP-BC, AOCNP, is an oncology nurse practitioner at the MD Anderson Cancer Center.
Alicia Michaelsen, BSN, RN, BMTCN®Alicia Michaelsen, BSN, RN, BMTCN®, is a nurse with over a decade of experience.
Fatemeh Youssefi, PhD, RN, OCNFatemeh Youssefi, PhD, RN, OCN, is a nurse who has specialized in oncology for the past 20 years.
Expert Interviews
Cancer Nursing Today delivers critical news and expert insights to support oncology nurses throughout their education and careers.
Sign up to receive Cancer Nursing Today eNewsletters:
Conference Highlights
Garg explained the importance of investigating disparities across racial and ethnic groups in the Hispanic community.
Dr. Loibl discusses the importance of involving nurses in breast cancer treatment to mitigate medication side effects.
Chronic GVHD can increase the risk of infections, graft failure, and multi-organ dysfunction in patients.
The open-label phase 2 clinical trial enrolled 33 patients with resectable, high-risk ccRCC.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.